Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
about
Pharmacogenetics-Based versus Conventional Dosing of Warfarin: A Meta-Analysis of Randomized Controlled Trials.Gene-drug interaction in strokePharmacogenomics of anti-platelet and anti-coagulation therapy.Pharmacogenomics of oral antiplatelet drugs.Pharmacogenetic studies with oral anticoagulants. Genome-wide association studies in vitamin K antagonist and direct oral anticoagulants.
P2860
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
@en
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
@nl
type
label
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
@en
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
@nl
prefLabel
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
@en
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
@nl
P2860
P1476
Implications of pharmacogenetic testing for patients taking warfarin or clopidogrel.
@en
P2093
David L Tirschwell
Megan M Donohue
P2860
P2888
P356
10.1007/S11910-010-0157-8
P577
2011-02-01T00:00:00Z